1546532
Last Update Posted: 2020-12-19
Recruiting has ended
All Genders accepted | 18 Years + |
118 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Renal Hemodynamic Effects of RLX030A in Subjects With Chronic Heart Failure (CHF)
This study will assess the renal hemodynamic effect of RLX030 infusion in subjects with chronic heart failure. In addition safety and effects on renal function and biomarkers will be assessed.
Eligibility
Relevant conditions:
Chronic Heart Failure (CHF)
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov